REQUEST A DEMO
Total
USD $0.00
Search more companies

Nanjing Pharmaceutical Company Limited (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Nanjing Pharmaceutical Company Limited Profile Updated: November 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Nanjing Pharmaceutical Company Limited is a pharmaceutical distribution company located in Nanjing. It has been operating in the Nanjing market for many years and has established a strong presence in both terminal and distribution channels. The company focuses on integrating health products and services through a comprehensive supply chain. Its core business is pharmaceutical logistics and value-added services. The company aims to provide integrated supply chain services based on order-oriented and pharmaceutical management services, offering health benefit management and services to the public and society. Nanjing Pharmaceutical Company Limited is ranked 212th among the top 500 companies in China in 2011. It is designated as a reserve unit for pharmaceutical equipment in Jiangsu, Anhui, Fujian, and Xinjiang Production and Construction Corps, as well as the designated unit for pharmaceutical equipment reserves for the General Logistics Department of the People's Liberation Army and the Navy. It is also recognized as a national-level demonstration enterprise for information technology and industrial integration. The company has been awarded a 3A credit rating by the China Association of Pharmaceutical Commerce. It is a founding unit of the China Medical Equipment Engineering Association and a standing council unit of the China Medical Insurance Research Association and the National Medical Insurance Association. Nanjing Pharmaceutical Company Limited is a member of the American Society of Health-System Pharmacists (ASHP), the United Natural Products Alliance (UNPA) in China, and the only partner of the Halal Certification Center of the Halal Industry Development Corporation (HDC) in Malaysia. The company aims to continue optimizing its innovative modern distribution service network based on the supply chain service system and strengthen its core competitiveness in the future.

Headquarters
9th Floor, Building A, Yunmi City, No. 19, Ningshuang Road, Yuhuatai District, Nanjing City, Jiangsu Province
Nanjing; Jiangsu; Postal Code: 210012

Contact Details: Purchase the Nanjing Pharmaceutical Company Limited report to view the information.

Website: http://www.njyy.com

Basic Information
Total Employees:
Purchase the Nanjing Pharmaceutical Company Limited report to view the information.
Outstanding Shares:
Purchase the Nanjing Pharmaceutical Company Limited report to view the information.
Registered Capital:
Purchase the Nanjing Pharmaceutical Company Limited report to view the information.
Financial Auditors:
Purchase the Nanjing Pharmaceutical Company Limited report to view the information.
Incorporation Date:
January 25, 1994
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
44.13%
Purchase this report to view the information.
11.03%
Purchase this report to view the information.
1.46%
Purchase this report to view the information.
0.38%
Purchase this report to view the information.
0.35%
Subsidiaries
Anhui Tianxing Pharmaceutical Supply Chain Co., Ltd.
100%
Anhui Tianxing Pharmacy Chain Co., Ltd.
100%
Fujian Huichun Pharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Nanjing Pharmaceutical Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
0.97%
Total operating revenue
0.95%
Operating profit (EBIT)
2.24%
Net Profit (Loss) for the Period
5.79%
Total assets
-2.25%
Total equity
6.79%
Operating Profit Margin (ROS)
0.02%
Net Profit Margin
0.07%
Return on Equity (ROE)
-0.07%
Debt to Equity Ratio
37.17%
Quick Ratio
0.13%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?